3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART®) combined with external beam radiation therapy

[1] Paganelli G(2007)IART®: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation Breast 16 17-26

[2] Ferrari M(2007)Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer Clin Cancer Res 13 5646s-5651s

[3] Cremonesi M(2010)Intraoperative avidination for radionuclide treatment as radiotherapy boost in breast cancer. Results of a phase II study with 90Y-labeled biotin Eur J Nucl Med Mol Imaging 37 203-211

[4] De Cicco C(2009)MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry – standardization of nomenclature J Nucl Med 50 477-484

[5] Galimberti V(1999)MIRD pamphlet No.16: techniques for quantitative radiopharmaceutical distribution data acquisition and analysis for use in human radiation dose estimates J Nucl Med 40 37S-61S

[6] Luini A(1999)MIRD pamphlet No.17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee J Nucl Med 40 11S-36S

[7] Paganelli G(2005)Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC J Nucl Med 46 1310-1316

[8] Ferrari M(2007)Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC Cancer Biother Radiopharm 22 406-416

[9] Ravasi L(2005)OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J Nucl Med 46 1023-1027

[10] Cremonesi M(2010)Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR-spheres: radiobiological considerations J Nucl Med 51 1377-1385

[1] Paganelli G(2007)IART®: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation Breast 16 17-26

[2] Ferrari M(2007)Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer Clin Cancer Res 13 5646s-5651s

[3] Cremonesi M(2010)Intraoperative avidination for radionuclide treatment as radiotherapy boost in breast cancer. Results of a phase II study with 90Y-labeled biotin Eur J Nucl Med Mol Imaging 37 203-211

[4] De Cicco C(2009)MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry – standardization of nomenclature J Nucl Med 50 477-484

[5] Galimberti V(1999)MIRD pamphlet No.16: techniques for quantitative radiopharmaceutical distribution data acquisition and analysis for use in human radiation dose estimates J Nucl Med 40 37S-61S

[6] Luini A(1999)MIRD pamphlet No.17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee J Nucl Med 40 11S-36S

[7] Paganelli G(2005)Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC J Nucl Med 46 1310-1316

[8] Ferrari M(2007)Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC Cancer Biother Radiopharm 22 406-416

[9] Ravasi L(2005)OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J Nucl Med 46 1023-1027

[10] Cremonesi M(2010)Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR-spheres: radiobiological considerations J Nucl Med 51 1377-1385